ÂÜÀòÂÒÂ×

Paul Sauter

Director Chemistry & Bioconjugation at Velabs Therapeutics

Paul Sauter is currently the Director Chemistry & Bioconjugation at VERAXA Biotech GmbH since January 2020. Prior to this role, they were the Head Of Chemistry at EMBL from May 2016 to December 2019. Paul Sauter obtained their Ph.D. in Organic Chemistry from Karlsruhe Institute of Technology (KIT) in March 2016.

Links

Previous companies

EMBL logo

Org chart